3Bowinsky E K.Cazenve L A,Donehower R C. A novel investigational antimicrotuble agent . J Natl Cancer Inst,1990,85:1247.
4Wani M C,Taglor H L,Wall M E.et al.Plant antitumor,agent. Ⅳ The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia. J Am Chen Soc.1971.93:2325.
5Mc Guire W P,Rowinsky E K. Paclitaxel in cancer treatment. Boston:Maccel Dekker Inc.1995.35--40.
6Holmes F A,Wshers R S,Theriault R L,et al. Phase Ⅱ study of takol in patients with untreated non-small cell lung cancer.J Natl Cancer Inst. 1991.83:1797-1805.
7Murphy W K.Fossella F V.Winn R J,et al. Phase Ⅱ study of takol in patients with untreated non-small cell lung cancer. J Natl Cancer Inst, 1993.85:384--388.
3Le Cesne A,Arriagada R,Grunenwald D,et al.New therapeutic strategies and cur rent research in inoperable locally advanced non small-cell lung cancers.Bull Cancer,1997,84:413-419.
4Watanabe H,Sajo N.Evidence based chemotherapy for lung cancer.Gan To Kagaku Ryoho,2000,27:30-43.
5Belani CP,Ramanathan RK.Combined modality treatment of locally advanced non -small cell lung cancer.Incorporation of novel chemotherapeutic agents.Chest,1998,113 S uppl 1:s53-s60.
6Le Chevalier T,Arriagada R,Tarayre M,et al.Significant effect of adjuvant che motherapy on survival in locally advanced non-small cell carcinoma.J Natl Cancer Inst,19 92,84:58.
7Sause WT,Scott C,Tayler S,et al.Radiation Therapy Oncology Group (RTOG)88- 08 and Eastern Cooperative Oncology Group (ECOG)4588:preliminary results of a phase Ⅲ trial in regionally advanced,unresectable non-small cell lung cancer.J Natl Cancer In st,1995,87:198- 205.
8Dillman RO,Herndon J,Seagren SL,et al.Improved survival in stage Ⅲ non-sm all cell lung cancer:seven year follow up of cancer and leukemia group B(CALGB)8433 trial.J Natl Cancer Inst,1996,88:1210-1215.
9Baldini E,Silvano G,Tilbaldi C,et al.Sequential chemoradiation therapy with vinorelbine,ifosfamide,and cisplatin in stage ⅢB non-small cell lung cancer: a phase Ⅱ study.Semin Oncol,2000,27(1 Suppl 1):s28-s32.
10Jeremic B,Shibamoto Y,Acimovic L,et al.Hyperfractionated radiation therapy wi th or without concurrent low-dose daily carboplatin/etoposide for stage Ⅲ non-small-cell lung cancer:a randomized study.J Clin oncol,1996,14:1065-1070.
1Laskin J J, Sandier AB. First-line treatment for advanced non-small cell lung cancer. Oncology (Williston Park), 2005, 19: 1671.
2Fukuda M, Shinkai T, Eguchi K, et al. Phase II study of (glycolate-0,0) diammineplatinum ( II ), a novel platinum comple,in the tleatment of non-small cell lung cancer. Cancer Chemother Pharmacol, 1990, 26: 393-396.
3Mcguire WP, Rowinsky EK. Paclitaxel in cancer treatment maccel dekker. Maccel Dekker Inc, 1995, 35: 40.
4Saijo N. New chemotherapeutic agents for treatment of non-small cell lung cancer the Japanese experience. Chest, 1998, 113: 17-23.
